Effective clinical response of lung adenocarcinoma harboring EGFR 19Del/T790M/in cis-C797S osimertinib to osimertinib and gefitinib combination therapy

Detalles Bibliográficos
Autores principales: Wang, Yanyan, Jiang, Chenchen, Tang, Mingyue, Li, Huiyuan, Zhao, Cancan, Zhao, Menglin, Zhang, Yue, Li, Xinwei, Mi, Jiaqi, Shen, Honghong, Wang, Zishu, Su, Fang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10423355/
https://www.ncbi.nlm.nih.gov/pubmed/37581042
http://dx.doi.org/10.21037/qims-22-1269

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10423355/
https://www.ncbi.nlm.nih.gov/pubmed/37581042
http://dx.doi.org/10.21037/qims-22-1269

Ejemplares similares